Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) - BSA Free Summary
| Immunogen |
Purified recombinant fragment of human Activin RIA/ALK-2/Activin Receptor Type 1 (AA: 21-120) expressed in E. Coli. |
| Isotype |
IgG1 |
| Clonality |
Monoclonal |
| Host |
Mouse |
| Gene |
ACVR1 |
| Purity |
Protein G purified |
| Innovator's Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase. |
Applications/Dilutions
| Dilutions |
- ELISA 1:10000
- Flow Cytometry 1:200-1:400
- Immunocytochemistry/ Immunofluorescence 1:10-1:500
- Immunohistochemistry 1:200-1:1000
- Immunohistochemistry-Paraffin 1:200-1:1000
- Western Blot 1:500-1:2000
|
| Theoretical MW |
57.2 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
Packaging, Storage & Formulations
| Storage |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer |
PBS |
| Preservative |
0.05% Sodium Azide |
| Concentration |
1 mg/ml |
| Purity |
Protein G purified |
Alternate Names for Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) - BSA Free
Background
Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are
guaranteed for 1 year from date of receipt.
Customers Who Viewed This Item Also Viewed...
Species: Hu
Applications: BA, BA
Species: Hu
Applications: BA
Species: Hu
Applications: CyTOF-ready, Flow, WB
Species: Hu
Applications: ELISA, ICC, WB
Species: Hu, Mu
Applications: ELISA, ICC/IF, WB
Species: Hu
Applications: IHC, Simple Western, WB
Species: Hu, Mu, Rt
Applications: BA
Species: Hu
Applications: IP, WB
Species: Hu, Mu
Applications: WB
Species: Hu, Mu, Rt
Applications: BA
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: Block, IHC, WB
Species: Hu
Applications: ELISA
Species: Hu
Applications: Block, IHC, WB
Species: Hu
Applications: CyTOF-ready, Flow, IHC
Species: Hu
Applications: BA
Species: Hu, Mu
Applications: ChIP, ICC, IHC, Simple Western, WB
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
Publications for Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (NBP2-61799) (0)
There are no publications for Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (NBP2-61799).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (NBP2-61799) (0)
There are no reviews for Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (NBP2-61799).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
Video Protocols
FAQs for Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (NBP2-61799) (0)
Secondary Antibodies
| |
Isotype Controls
|
Additional Activin RIA/ALK-2/Activin Receptor Type 1 Products
Research Areas for Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (NBP2-61799)
Find related products by research area.
|
Blogs on Activin RIA/ALK-2/Activin Receptor Type 1
![Western Blot: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis using ACVR1 mAb against human ACVR1 (AA: 21-120) recombinant protein. (Expected MW is 37.1 kDa)](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2E2C11-Western-Blot-NBP2-61799-img0007.jpg "Western Blot: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis using ACVR1 mAb against human ACVR1 (AA: 21-120) recombinant protein. (Expected MW is 37.1 kDa)")
![Immunocytochemistry/Immunofluorescence: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis of Hela cells using ACVR1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Goat anti-Mouse IgG (H+L) DyLight 488 Secondary antibody was used.](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2E2C11-Immunocytochemistry-Immunofluorescence-NBP2-61799-img0004.jpg "Immunocytochemistry/Immunofluorescence: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis of Hela cells using ACVR1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Goat anti-Mouse IgG (H+L) DyLight 488 Secondary antibody was used.")
![Immunohistochemistry-Paraffin: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis of endometrial cancer tissues using ACVR1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2E2C11-Immunohistochemistry-NBP2-61799-img0006.jpg "Immunohistochemistry-Paraffin: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis of endometrial cancer tissues using ACVR1 mouse mAb with DAB staining.")
![Western Blot: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis using ACVR1 mAb against HEK293 (1) and ACVR1 (AA: 21-120)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2E2C11-Western-Blot-NBP2-61799-img0008.jpg "Western Blot: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis using ACVR1 mAb against HEK293 (1) and ACVR1 (AA: 21-120)-hIgGFc transfected HEK293 (2) cell lysate.")
![Immunocytochemistry/Immunofluorescence: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis of Hela cells using ACVR1 mouse mAb. Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2E2C11-Immunocytochemistry-Immunofluorescence-NBP2-61799-img0003.jpg "Immunocytochemistry/Immunofluorescence: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis of Hela cells using ACVR1 mouse mAb. Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.")
![Immunohistochemistry-Paraffin: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis of ovarian cancer tissues using ACVR1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2E2C11-Immunohistochemistry-NBP2-61799-img0005.jpg "Immunohistochemistry-Paraffin: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis of ovarian cancer tissues using ACVR1 mouse mAb with DAB staining.")
![ELISA: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2E2C11-ELISA-NBP2-61799-img0001.jpg "ELISA: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)")
![ELISA: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis of Hela cells using ACVR1 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-2E2C11-ELISA-NBP2-61799-img0002.jpg "ELISA: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody (2E2C11) [NBP2-61799] - Analysis of Hela cells using ACVR1 mouse mAb (green) and negative control (red).")
![SDS-PAGE BMP-4 [Unconjugated]](https://images.novusbio.com/images2/BMP-4_314-BP_100.jpg)
![Bioactivity BMP-4 [Unconjugated]](https://images.novusbio.com/images2/314-bp_recombinant-human-bmp-4-protein-1882021123744.jpg)
![Bioactivity BMP-7 [Unconjugated]](https://images.novusbio.com/images/protein/354-bp_recombinant-human-bmp-7-protein-bioactivity-7122020141940.jpg)
![Cell Culture BMP-7 [Unconjugated]](https://images.novusbio.com/images/354-bp_recombinant-human-bmp-7-protein-cell-culture-252023113257..jpg)
![Western Blot BMPR-IA/ALK-3 Antibody [Unconjugated]](https://images.novusbio.com/images2/BMPR-IA_AF346_Western_Blot_9327.jpg)
![Immunohistochemistry BMPR-IA/ALK-3 Antibody [Unconjugated]](https://images.novusbio.com/images2/af346_human-bmpr-ia-alk-3-affinity-purified-polyclonal-ab-immunohistochemistry-35202018211.jpg)
![Western Blot TGF-beta RI/ALK-5 Antibody [Unconjugated]](https://images.novusbio.com/images2/TGFbeta_RI_AF3025_Western_Blot_17081.jpg)
![Immunocytochemistry TGF-beta RI/ALK-5 Antibody [Unconjugated]](https://images.novusbio.com/images2/TGF-beta_RI_AF3025_Immunocytochemistry_9948.jpg)
![Western Blot TGF-beta RI/ALK-5 Antibody [Unconjugated]](https://images.novusbio.com/images/af3025_human-tgf-beta-ri-alk-5-affinity-purified-polyclonal-ab-41202412402510.jpg)
![Immunohistochemistry Smad1 Antibody [Unconjugated]](https://images.novusbio.com/images2/Smad1_AF2039_Immunohistochemistry_10106.jpg)
![Western Blot Smad1 Antibody [Unconjugated]](https://images.novusbio.com/images2/Smad1_AF2039_Western_Blot_5162.jpg)
![Simple Western Smad1 Antibody [Unconjugated]](https://images.novusbio.com/images2/Smad1_AF2039_Simple_Western_16677.jpg)
![Bioactivity BMP-2 [Unconjugated]](https://images.novusbio.com/images/protein/355-bm_recombinant-human-mouse-rat-bmp-2-protein-bioactivity-181120209742.jpg)
![Immunohistochemistry Activin RIIA Antibody [Unconjugated]](https://images.novusbio.com/images2/Activin_RIIA_AF340_Immunohistochemistry_6785.jpg)
![N/A SLPI [HRP]](https://images.novusbio.com/images2/DATA_SLPI_DPI00_ELISA_792.jpg)
![N/A SLPI [HRP]](https://images.novusbio.com/images2/SLPI_DPI00_ELISA_160.jpg)
![Flow Cytometry BMPR-II Antibody [Unconjugated]](https://images.novusbio.com/images2/BMPRII_AF811_Flow_Cytometry_15364.jpg)
![Immunohistochemistry BMPR-II Antibody [Unconjugated]](https://images.novusbio.com/images2/BMPR-II_AF811_Immunohistochemistry_7345.jpg)
![SDS-PAGE BMP-6 [Unconjugated]](https://images.novusbio.com/images2/BMP-6_507-BP_374.jpg)
![Bioactivity BMP-6 [Unconjugated]](https://images.novusbio.com/images2/BMP-6_507-BP_376.jpg)
![Western Blot Smad2/3 Antibody [Unconjugated]](https://images.novusbio.com/images2/Smad3_AF3797_Western_Blot_5347.jpg)
![Chromatin Immunoprecipitation (ChIP) Smad2/3 Antibody [Unconjugated]](https://images.novusbio.com/images2/Smad3_AF3797_Chromatin_Immunoprecipitation_11240.jpg)
![Immunocytochemistry Smad2/3 Antibody [Unconjugated]](https://images.novusbio.com/images2/Smad3_AF3797_Immunocytochemistry_11829.jpg)
![Bioactivity TGF-beta 1 [Unconjugated]](https://images.novusbio.com/images/protein/7754-bhcf_recombinant-human-tgf-beta-1-human-cell-expressed-cf-bioactivity-1811202013946.jpg)
![SDS-PAGE BMP-9 [Unconjugated]](https://images.novusbio.com/images2/BMP-9_3209-BP_CF_568.jpg)
![Bioactivity BMP-9 [Unconjugated]](https://images.novusbio.com/images2/BMP-9_3209-BP_CF_618.jpg)
![Immunocytochemistry/ Immunofluorescence Smad5 [p Ser463, p Ser465] Antibody (SY09-03)](https://images.novusbio.com/images/Smad5-p-Ser463-p-Ser465-Antibody-SY09-03-Immunocytochemistry-Immunofluorescence-NBP2-67394-img0001.jpg)
![Immunocytochemistry/ Immunofluorescence Smad5 [p Ser463, p Ser465] Antibody (SY09-03)](https://images.novusbio.com/images/Smad5-p-Ser463-p-Ser465-Antibody-SY09-03-Immunocytochemistry-Immunofluorescence-NBP2-67394-img0002.jpg)
![Immunohistochemistry-Paraffin Smad5 [p Ser463, p Ser465] Antibody (SY09-03)](https://images.novusbio.com/images/Smad5-p-Ser463-p-Ser465-Antibody-SY09-03-Immunohistochemistry-Paraffin-NBP2-67394-img0003.jpg)
![SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.](https://images.novusbio.com/images/Mouse-IgG1-Isotype-Control-MG1-SDS-Page-NBP1-97005-img0002.jpg "SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.")